Table 4.
Retention | X2 | p – value | |||
---|---|---|---|---|---|
Yes | No | ||||
Age | <15 | 18 (42.9) | 24 (57.1) | 10.672 | 0.031 |
15 – 19 | 1 (50.0) | 1 (50.0) | |||
20 - 25 | 20 (51.3) | 19 (48.7) | |||
26 – 49 | 259 (65.2) | 138 (34.8) | |||
≥50 | 49 (65.3) | 26 (34.7) | |||
Sex | 1.044 | 0.307 | |||
Female | 243 (63.9) | 137 (36.1) | |||
Male | 104 (59.4) | 71 (40.6) | |||
ART Status | 50.135 | 0.000 | |||
Yes | 335 (67.5) | 161 (32.5) | |||
No | 12 (20.3) | 47 (79.7) | |||
CD4 Count | 15.500 | 0.004 | |||
≤100 | 101 (66.9) | 50 (33.10 | |||
101 – 200 | 75 (59.5) | 51 (40.5) | |||
201 – 300 | 69 (72.6) | 26 (38.1) | |||
301 – 400 | 48 (66.7) | 24 (33.3) | |||
>400 | 54 (48.6) | 57 (51.4) | |||
WHO Stage at Diagnosis | 5.666 | 0.129 | |||
1 | 94 (59.1) | 65 (40.9) | |||
2 | 76 (72.4) | 29 (27.6) | |||
3 | 99 (61.9) | 61 (38.1) | |||
4 | 78 (59.5) | 53 (40.5) | |||
Year of Diagnosis | 7.234 | 0.027 | |||
2005 – 2007 | 83 (72.8) | 31 (27.2) | |||
2008 – 2009 | 104 (57.5) | 77 (42.5) | |||
2010 – 2011 | 160 (61.5) | 100 (38.5) | |||
Year of Initiation | 7.234 | 0.027 | |||
2005 – 2007 | 83 (72.8) | 31 (27.2) | |||
2008 – 2009 | 104 (57.5) | 77 (42.5) | |||
2010 – 2011 | 160 (61.5) | 100 (38.5) |